CervoMed Inc

CRVO30 Nov 2024
Healthcare
$9.27
+0.18 (+17.97%)
Lowest Today
$9.16
Highest Today
$11.5
Today’s Open
$9.27
Prev. Close
$9.16
52 Week High
$26.38
52 Week Low
$5.85
To Invest in CervoMed Inc

CervoMed Inc

Healthcare
CRVO30 Nov 2024
+0.18 (+17.97%)
1M
3M
6M
1Y
5Y
Low
$9.16
Day’s Range
High
$11.5
9.16
52 Week Low
$5.85
52-Week Range
52 Week High
$26.38
5.85
1 Day
-
1 Week
+17.17%
1 month return
-24.96%
3 month return
-42.64%
6 month return
-46.84%
1 Year return
+7.71%
3 Years return
-62.28%
5 Years return
-69.92%
10 Years return
-

Market Status

Fundamentals
Market Cap
75.56 mln
PB Ratio
1.66
PE Ratio
0
Enterprise Value
28.91 mln
Total Assets
9.97 mln
Volume

Company Financials

Fund house & investment objective

Company Information
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Organisation
CervoMed Inc
Employees
8
Industry
Biotechnology
CEO
Dr. John J. Alam M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step